Rule Change Frees Unapproved Tests To Play Bigger Role In Emergencies
This article was originally published in The Gray Sheet
Executive Summary
FDA is amending its regulations to make it easier for a physician to test a patient for possible exposure to a terrorism-based or other infectious disease agent with an unapproved diagnostic without prior informed consent